REFERENCES
- Aungst B. J., Rogers N. J., Shefter E. Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int. J. Pharm. 1986; 33: 225–234
- Barry B. W. Dermatological Formulations. Marcel Dekker, New York 1983; 49–94
- Buckley M. M., Brogden R. N. Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 1990; 39: 86–109
- Cho Y. A., Gwak H. S. Transdermal delivery of ketorolac tromethamine: effects of vehicles and penetration enhancers. Drug Dev. Ind. Pharm. 2004; 30: 557–564
- Cho Y. J., Choi H. K. Enhancement of percutaneous absorption of ketoprofen: effect of vehicles and adhesive matrix. Int. J. Pharm. 1998; 169: 95–104
- Cooper E. R. Increased skin permeability for lipophilic molecules. J. Pharm. Sci. 1984; 73: 153–1156
- Cooper E. R., Merritt E. W., Smith R. L. Effect of fatty acids and alcohols on the penetration of acyclovir across human skin in vitro. J. Pharm. Sci. 1985; 74: 688–689
- Forbes J. A., Butterworth G. A., Burchfield W. H., Beaver A. T. Evaluation of ketorolac, aspirin and acetaminophen-codeine combination in postoperative oral surgery pain. Pharmacotherapy 1990; 10: 77S–93S
- Grandos-Soto V., Lopez-Munoz F. J., Hong E., Fluores-Murrieta F. J. Relationship between pharmacokinetics and the analgesic effect of ketorolac in the rat. J. Pharmacol. Exp. Ther. 1995; 272: 352–356
- Nomura H., Fusao K., Sugimoto Y., Miyashita Y., Dohi M., Kato Y. Percutaneous absorption of indomethacin from mixtures of fatty alcohol and propylene glycol (FAPG bases) through rat skin: effects of oleic acid added to FAPG base. Chem. Pharm. Bull. 1990; 38: 1421–1424
- O'Hara D. A., Fragen R. J., Kinzer M., Pemberton D. Ketorolac tromethamine as compared with morphine sulfate for treatment of postoperative pain. Clin. Pharmacol. Ther. 1987; 41: 556–561
- Pasloske K., Renaud R., Burger J., Conlon P. Pharmacokinetics of ketorolac after intravenous and oral single dose administration in dogs. J. Vet. Pharmacol. Ther. 1999; 22: 314–319
- Reinhart D. I. Minimizing the adverse effects of ketorolac. Drug Safety 2000; 22: 487–497
- Rooks W. H., Maloney P. J., Shott L. D., Schuler M. E., Sevelius H., Strosberg A. M., Tanenbaum L., et al. The analgesic and anti-inflammatory profile of ketorolac and its tromethamine salt. Drugs Exp. Clin. Res. 1985; 11: 479–492
- Stanski D. R., Cherry C., Bradley R., Sarnquist F. H., Yee J. P. Efficacy and safety of single doses of intramuscular ketorolac tromethamine compared with meperidine for postoperative pain. Pharmacotherapy 1990; 10: 40S–44S
- Tiwari S. B., Udupa N. Investigation into the potential of iontophoresis facilitated delivery of ketorolac. Int. J. Pharm. 2003; 260: 93–103
- Yamada M., Uda Y., Tanigawara Y. Mechanism of enhancement of percutaneous absorption of molsidomine by oleic acid. Chem. Pharm. Bull. 1987; 35: 3399–3406
- Yee J. P., Koshiver J. V., Allbon C., Brown C. R. Comparison of intramuscular ketorolac tromethamine and morphine sulfate for analgesia of pain after major surgery. Pharmacotherapy 1986; 6: 253–261